Evidence map›Paper›PMID 26776507›Full record

ArticleCell reports2016

Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.

Patrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, Nirmalya Sen, Sara Haddock, Matt L Harlow, Nichole K Maloney, Jack Zhu, Maura O'Neill, Tamara L Jones and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. HNRNPH1-mediated splicing events regulatebioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
    Review
  16. Review
  17. Article
  18. RNA-binding proteins of COSMIC importance in cancer.The Journal of clinical investigation · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Patrick J GroharDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Suntae KimGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Guillermo O Rangel RiveraGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; NIH Academy, Office of Intramural Training and Education, NIH, Bethesda, MD 20892, USA.
Nirmalya SenGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Sara HaddockGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Matt L HarlowDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Nichole K MaloneyDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jack ZhuMolecular Genetics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Maura O'NeillProtein Characterization Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Tamara L JonesGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Konrad HuppiGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Magdalena GrandinGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Kristen GehlhausGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Carleen A Klumpp-ThomasTrans-NIH RNAi Screening Facility, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA.
Eugen BuehlerTrans-NIH RNAi Screening Facility, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA.
Lee J HelmanMolecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Scott E MartinTrans-NIH RNAi Screening Facility, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA.
Natasha J CaplenGene Silencing Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: ncaplen@mail.nih.gov.
Center for Cancer Research · USNational Cancer Institute · USNational Center for Advancing Translational Sciences · USVanderbilt University · USFrederick National Laboratory for Cancer Research · US

Funding

Discovery of genes required for expression or activity of fusion oncogenesZIABC011704 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CAPLEN, NATASHA · 2016 to 2025
$15.8M
Trans-NIH RNAi Facility (TNRF)ZICTR000041 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI CHENG, KEN · 2015 to 2025
$9.4M
The Induction of Gene-specific RNAi Against Cancer-associated GenesZIABC010613 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CAPLEN, NATASHA · 2009 to 2015
$2.4M
RNAi Screening for the Systematic Discovery of Cancer Gene FunctionZIABC010615 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CAPLEN, NATASHA · 2009 to 2015
$2.0M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC010613Intramural NIH HHS ZIA BC010615NCI NIH HHS HHSN261200800001EPHS HHS HHSN261200800001E;
6 · The paper itself

Abstract

Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide RNAi screening, we have identified proteins required for the processing of the EWS-FLI1 pre-mRNA. We show that Ewing sarcoma cells harboring a genomic breakpoint that retains exon 8 of EWSR1 require the RNA-binding protein HNRNPH1 to express in-frame EWS-FLI1. We also demonstrate the sensitivity of EWS-FLI1 fusion transcripts to the loss of function of the U2 snRNP component, SF3B1. Disrupted splicing of the EWS-FLI1 transcript alters EWS-FLI1 protein expression and EWS-FLI1-driven expression. Our results show that the processing of the EWS-FLI1 fusion RNA is a potentially targetable vulnerability in Ewing sarcoma cells.

Indexed as

Base SequenceBinding SitesCalmodulin-Binding ProteinsCell Line, TumorCell SurvivalExonsGene Expression Regulation, NeoplasticHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansMicrofilament ProteinsOncogene Proteins, FusionPhosphoproteinsProto-Oncogene Protein c-fli-1Receptors, Cytoplasmic and NuclearRibonucleoprotein, U2 Small NuclearRNA-Binding Protein EWSCalmodulin-Binding ProteinsEWS-FLI fusion proteinEWSR1 protein, humanFLII protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HMicrofilament ProteinsOncogene Proteins, FusionPhosphoproteinsProto-Oncogene Protein c-fli-1Receptors, Cytoplasmic and NuclearRibonucleoprotein, U2 Small NuclearRNA-Binding Protein EWSRNA-Binding ProteinsRNA PrecursorsRNA, Small InterferingRNA Splicing FactorsSF3B1 protein, humanSUPT6H protein, humanTrans-ActivatorsTranscription Factors

Identifiers

PMID26776507
PMCPMC4755295
OpenAlexW2236416891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.